Surfactant Associated Protein-A Inhibits Human Lymphocyte Proliferation and IL-2 Production

American Journal of Respiratory Cell and Molecular Biology

Volumn 15, Issue 1, 1996, Pages 115-121

  Borron, Paul ^a,b   Veldhuizen, Ruud A W ^a   Lewis, James F ^a   Possmayer, Fred ^a   Caveney, Anita ^a   Inchley, Kevin ^a   McFadden, Robin G ^a   Fraher, Laurence J ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CONCANAVALIN A; GLYCOPROTEIN; INTERLEUKIN 2; LUNG SURFACTANT; MONOCLONAL ANTIBODY; PROTEOLIPID; RECOMBINANT PROTEIN; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A;

ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; CELL DIVISION; CELL LINE; DRUG EFFECT; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MONOCYTE; PNEUMONIA; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CATTLE; CELL DIVISION; CELL LINE; CONCANAVALIN A; GLYCOPROTEINS; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MONOCYTES; PNEUMONIA; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 0030191828     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.15.1.8679215     Document Type: Article

References (55)

1. Kaltreider, H. B., and S. E. Salmon. 1973. Functional properties of bronchoalveolar lymphocytes obtained from the normal canine lung. J. Clin. Invest. 52:2211-2217.
2. Robinson, B. W. S., P. Pinkston, and R. G. Crystal. 1984. Natural killer cells are present in the normal lung but are functionally impotent. J. Clin. Invest. 74:942-950.
3. Lipscomb, M. F., C. R. Lyons, G. Nunez, E. J. Ball, P. Stastny, W. Vial, V. Lem, J. Weissler, L. M. Miller, and G. B. Toews. 1986. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J. Immunol. 136:497-504.
4. Lecossier, D., D. Valeyre, A. Loiseau, J.-P. Battesti, P. Soler, and A. J. Hance. 1988. T-lymphocytes recovered by bronchoalveolar lavage from normal subjects and patients with sarcoidosis are refractory to proliferative signals. Am. Rev. Respir. Dis. 137:592-599.
5. Ansfield, M. J., H. B. Kaltrieder, J. L. Caldwell, and F. N. Herskowitz. 1979. Hyporesponsiveness of canine bronchoalveolar lymphocytes to mitogens: inhibition of lymphocyte proliferation by alveolar macrophages. J. Immunol. 122:542-548.
6. Marathias, K., C. Pinto, G. Rodberg, F. Preffer, J. Wong, and R. Kradin. 1994. The T cell antigen receptor CD3:CD4 molecular complex is diminished on the surface of pulmonary lymphocytes. Am. J. Pathol. 145:1212-1227.
7. 1 to suppress lymphocyte activation. J. Leukocyte Biol. 53:366-371.
8. Ettensohn, D. B., P. A. Lalor, and N. J. Roberts Jr. 1986. Human alveolar macrophage regulation of lymphocyte proliferation. Am. Rev. Respir. Dis. 133:1091-1096.
9. Holt, P. G., J. Oliver, N. Bilyk, C. McMenamin, P. G. McMenamin, G. Kraal, and T. Thepen. 1993. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177:397-407.
10. Ansfield, M. J., H. B. Kaltreider, B. J. Benson, and M. R. Shalby. 1980. Canine surface active material and pulmonary lymphocyte function studies with mixed-lymphocyte culture. Exp. Lung Res. 1:3-11.
11. Sitrin, R. G., M. J. Ansfield, and H. B. Kaltreider. 1985. The effect of pulmonary surface-active material on the generation and expression of murine B- and T-lymphocyte effector functions in vitro. Exp. Lung Res. 9:85-97.
12. Hayakawa, H., Q. N. Myrvik, and R. W. St. Clair. 1989. Pulmonary surfactant inhibits priming of rabbit alveolar macrophage. Am. Rev. Respir. Dis. 140:1390-1397.
13. Wilsher, M. L., D. A. Hughes, and P. L. Haslam. 1988. Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes. Thorax 43:354-359.
14. Wilsher, M. L., D. A. Hughes, and P. L. Haslam. 1988. Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile. Clin. Exp. Immunol. 73:117-122.
15. Ansfield, M. J., and B. J. Benson. 1980. Identification of the immunosuppressive components of canine pulmonary surface active material. J. Immunol. 125:1093-1098.
16. Kremlev, S. G., T. M. Umstead, and D. S. Phelps. 1994. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am. J. Physiol. (Lung Cell Mol. Physiol.) 267:L357-L364.
17. Sastry, K., and R. A. Ezekowitz. 1993. Collectins: pattern recognition molecules involved in first line host defense. Curr. Opin. Immunol. 5:59-66.
18. Wilsher, L., D. J. Parker, and P. L. Haslam. 1990. Immunosuppression by pulmonary surfactant: mechanisms of action. Thorax 45:3-8.
19. Richman, P. S., S. Butcher, and A. Catanzaro. 1990. Pulmonary surfactant suppresses the immune lung injury response to inhaled antigen in guinea pigs. J. Lab. Clin. Med. 116:18-26.
20. Holmskov, U., R. Malhotra, R. B. Sim, and J. C. Jensenius. 1994. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol. Today 15:67-74.
21. Zimmerman, P. E., D. R. Voelker, F. X. McCormack, J. R. Paulsrud, and W. J. Martin. 1992. 120-KD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J. Clin. Invest. 89:143-149.
22. Geertsma, M. F., P. H. Nibbering, H. P. Haagsman, M. R. Daha, and R. Van Furth. 1994. Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. Am. J. Physiol. 267 (Lung Cell Mol. Physiol.) 11:L578-L584.
23. Van Iwaarden, F., B. Welmers, J. Verhoef, H. P. Haagsman, and L. M. G. van Golde. 1990. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2:91-98.
24. Manz-Keinke, H., H. Plattner, and J. Schlepper-Schafer. 1992. Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages. Eur. J. Cell Biol. 57:95-100.
25. Van Iwaarden, J. F., J. A. G. van Strijp, M. J. M. Ebskamp, A. C. Welmers, J. Verhoef, and L. M. G. van Golde. 1991. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages. Am. J. Physiol. 261 (Lung Cell Mol. Physiol.) 5:L204-L209.
26. Malhotra, R., J. S. Haurum, S. Thiel, and R. B. Sim. 1994. Binding of human collectins (SP-A and MBP) to influenza virus. Biochem. J. 304:455-461.
27. Hoffman, R. M., W. D. Claypool, S. L. Katyal, G. Singh, R. M. Rogers, and J. H. Dauber. 1987. Augmentation of rat alveolar macrophage migration by surfactant protein. Am. Rev. Respir. Dis. 135:1358-1362.
28. Katsura, H., H. Kawada, and K. Konno. 1993. Rat surfactant Apoprotein A (SP-A) exhibits antioxidant effects on alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:520-525.
29. Weber, H., P. Heilmann, B. Meyer, and K. L. Maier. 1990. Effect of canine surfactant protein A (SP-A) on the respiratory burst of phagocytic cells. FEBS Lett. 270:90-94.
30. Walker, C., W. Bauer, R. K. Braun, G. Menz, F. Schwarz, T. T. Hansel, and B. Villager. 1994. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 150:1038-1048.
31. Gavett, S. H., X. Chen, F. Finkelman, and M. Wills-Karp. 1994. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hypersensitivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587-593.
32. Sabath, D. E., and M. B. Prystowsky. 1990. The molecular basis of Interleukin-2 action. In Lymphokines and the Immune Response. S. Cohen, editor. CRC Press, Boca Raton, FL. 181-197.
33. Cockshutt, A. M., J. Weitz, and F. Possmayer. 1990. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29:8424-8429.
34. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin reagent. J. Biol. Chem. 193:265-275.
35. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
36. 3 (calcitriol). Am. J. Respir. Cell Mol. Biol. 4:42-49.
37. Goldsmith, M. A., and A. Weiss. 1987. Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. Proc. Natl. Acad. Sci. USA 84:6879-6883.
38. Johansson, J., T. Cursted, and B. Robertson. 1994. The proteins of the surfactant system. Eur. Respir. J. 7:372-391.
39. Corrigan, C. J., and A. B. Kay. 1992. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today 13:501-507.
40. Espinoza-Delgado, I., M. C. Bosco, T. Musso, G. L. Gusella, D. L. Longo, and L. Varesio. 1995. Interleukin-2 and human monocyte activation. J. Leukocyte Biol. 57:13-19.
41. Muller-Quernheim, J., S. Pfeifer, J. Strausz, and R. Ferlinz. 1991. Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am. Rev. Respir. Dis. 144:1322-1329.
42. Kanellopoulos, J. M., S. DePetris, G. Leca, and M. J. Crumpton. 1985. The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes. Eur. J. Immunol. 15:479-486.
43. Holter, W., O. Majdic, H. Stockinger, B. H. Howard, and W. Knapp. 1988. Regulation of the CD2 alternate pathway of T cell activation by CD3. J. Immunol. 140:1043-1046.
44. Hashimoto, S., C. C. McCombs, and J. P. Michalski. 1993. Evidence for an ongoing role of class I histocompatibility molecules for the production of interleukin-2 in response to suboptimal concentrations of phytohaemagglutinin. Scand. J. Immunol. 37:541-549.
45. Larsen, C. S. 1990. Activation of human T lymphocytes by phorbol-12,13 dibutyrate and ionomycin. Scand. J. Immunol. 31:353-360.
46. Gupta, S., M. Shimizu, K. Ohira, and B. Vayuvegula. 1991. T cell activation via the T cell receptor: a comparison between WT31 (defining a/b TcR)-induced and anti-CD3-induced activation of human T lymphocytes. Cell. Immunol. 132:26-44.
47. Nash, P. V., and A. M. Mastro. 1993. Activation of primary lymphocytes requires prolonged lectin stimulation. J. Leukocyte Biol. 53:73-78.
48. Korfhagen, T. R., M. D. Bruno, S. W. Glasser, P. J. Ciralo, J. A. Whitsett, D. L. Lattier, K. A. Wikenheiser, and J. C. Clark. 1992. Murine pulmonary surfactant SP-A gene: cloning, sequence, and transcriptional activity. Am. J. Physiol. 263:L546-L554.
49. Boggaram, V., K. Qing, and C. R. Mendelson. 1988. The major apoprotein of rabbit pulmonary surfactant. Elucidation of primary sequence and cyclic AMP and developmental regulation. J. Biol. Chem. 263:2939-2947.
50. Drickamer, K., M. S. Dordal, and L. Reynolds. 1986. Mannose binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein. J. Biol. Chem. 261:6878-6887.
51. Benson, B., S. Hawgood, J. Schilling, J. Clements, D. Damm, B. Cordell, and R. T. White. 1985. Structure of canine pulmonary surfactant apoprotein: cDNA and complete amino acid sequence. Proc. Natl. Acad. Sci. USA 82:6379-6383.
52. Strayer, D. S. 1993. Surfactant protein A binding proteins: characterization and structure. J. Biol. Chem. 268:18679-18684.
53. Larson, R. S., and T. A. Springer. 1990. Structure and function of leukocyte integrins. Immunol. Rev. 114:181-207.
54. Bartmann, P., L. Gortner, F. Pohlandt, and H. Jaeger. 1992. In vitro lymphocyte functions in the presence of bovine surfactant and its phospholipid fractions. J. Perinat. Med. 20:189-196.
55. Catanzaro, A., P. Richman, S. Batcher, and M. Hallman. 1988. Immunomodulation by pulmonary surfactant. J. Lab. Clin. Med. 112:727-734.